EP3033098
RECOMBINANT FACTOR VIII PROTEINS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.8.2014EP published:
22.6.2022EP application number:
14835927.6
EPO information:
European Patent Register
Max expiry date:
13.8.2034
Title in English:
RECOMBINANT FACTOR VIII PROTEINSLanguage of the patent:
English
Timeline
Today
14.8.2014EP application
22.6.2022EP Publication
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, Waltham, MA 02451, US
Inventor
Name:
PETERS, Robert T.Address:
Needham, Massachusetts 02492, US
Name:
KULMAN, JohnAddress:
Belmont, Massachusetts 02478, US
Priority
Number:
201361866017 PDate:
14.8.2013Country:
US
Classification
Categories:
A61K 38/36, A61K 38/37, A61K 35/14, C07K 1/00, C07K 14/745, C07K 14/755, C07K 7/08, C07K 14/49, C07K 14/76, C07K 14/705, C07K 14/59, C07K 14/00, A61K 38/00, C07K 14/79, A61P 7/04, A61K 47/60, A61K 47/61, A61K 47/54